☰

Ivan V. Litvinov, Ph.D. - Publications

Affiliations: 
2006 Johns Hopkins University, Baltimore, MD 
Area:
Cell Biology, Molecular Biology
Tree Info Similar researchers PubMed Report error

49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Muntyanu A, Netchiporouk E, Gerstein W, Gniadecki R, Litvinov IV. Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management. Journal of Cutaneous Medicine and Surgery. 1203475420943260. PMID 32746624 DOI: 10.1177/1203475420943260  0.3
2020 Martínez Villarreal A, Gantchev J, Lagacé F, Barolet A, Sasseville D, Ødum N, Charli-Joseph YV, Hernández Salazar A, Litvinov IV. Hypopigmented Mycosis Fungoides: Loss of Pigmentation Reflects Antitumor Immune Response in Young Patients. Cancers. 12. PMID 32707930 DOI: 10.3390/Cancers12082007  0.328
2020 Cattelan L, Ghazawi FM, Le M, Savin E, Zubarev A, Lagacé F, Sasseville D, Waschke K, Litvinov IV. Investigating epidemiologic trends and the geographic distribution of patients with anal squamous cell carcinoma throughout Canada. Current Oncology (Toronto, Ont.). 27: e294-e306. PMID 32669936 DOI: 10.3747/Co.27.6061  0.338
2020 Willerslev-Olsen A, Buus TB, Nastasi C, Blümel E, Gluud M, Bonefeld CM, Geisler C, Lindahl LM, Vermeer M, Wasik MA, Iversen L, Becker JC, Andersen MH, Gjerdrum LMR, Litvinov IV, et al. Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome. Blood Cancer Journal. 10: 57. PMID 32409671 DOI: 10.1038/S41408-020-0324-3  0.364
2020 Le M, Ghazawi FM, Netchiporouk E, Litvinov IV. The Novel Role of Antibiotic Treatment in the Management of Cutaneous T-Cell Lymphoma (CTCL) Patients. Journal of Cutaneous Medicine and Surgery. 1203475420926981. PMID 32394726 DOI: 10.1177/1203475420926981  0.31
2020 Gantchev J, Martínez Villarreal A, Gunn S, Zetka M, Ødum N, Litvinov IV. The ectopic expression of meiCT genes promotes meiomitosis and may facilitate carcinogenesis. Cell Cycle (Georgetown, Tex.). 1-18. PMID 32223693 DOI: 10.1080/15384101.2020.1743902  0.322
2019 Cattelan L, Ghazawi FM, Le M, Lagacé F, Savin E, Zubarev A, Gantchev J, Tomaszewski M, Sasseville D, Waschke K, Litvinov IV. Epidemiologic trends and geographic distribution of esophageal cancer in Canada: A national population-based study. Cancer Medicine. PMID 31715645 DOI: 10.1002/Cam4.2700  0.306
2019 Sivanand A, Surmanowicz P, Alhusayen R, Hull P, Litvinov IV, Zhou Y, Gniadecki R. Immunotherapy for Cutaneous T-Cell Lymphoma: Current Landscape and Future Developments. Journal of Cutaneous Medicine and Surgery. 1203475419867610. PMID 31353944 DOI: 10.1177/1203475419867610  0.331
2019 Gantchev J, Martínez Villarreal A, Xie P, Lefrançois P, Gunn S, Netchiporouk E, Sasseville D, Litvinov IV. The Ectopic Expression of Meiosis Regulatory Genes in Cutaneous T-Cell Lymphomas (CTCL). Frontiers in Oncology. 9: 429. PMID 31214493 DOI: 10.3389/Fonc.2019.00429  0.362
2019 Ghazawi FM, Alghazawi N, Le M, Netchiporouk E, Glassman SJ, Sasseville D, Litvinov IV. Environmental and Other Extrinsic Risk Factors Contributing to the Pathogenesis of Cutaneous T Cell Lymphoma (CTCL). Frontiers in Oncology. 9: 300. PMID 31106143 DOI: 10.3389/Fonc.2019.00300  0.339
2019 Gantchev J, Martínez Villarreal A, Litvinov I. 478 Expression of meiosis regulatory genes in cutaneous T-cell lymphoma Journal of Investigative Dermatology. 139: S297. DOI: 10.1016/J.Jid.2019.07.528  0.32
2018 Tsang M, Gantchev J, Netchiporouk E, Moreau L, Ghazawi FM, Glassman S, Sasseville D, Litvinov IV. A study of meiomitosis and novel pathways of genomic instability in cutaneous T-cell lymphomas (CTCL). Oncotarget. 9: 37647-37661. PMID 30701021 DOI: 10.18632/Oncotarget.26479  0.332
2018 Buus TB, Willerslev-Olsen A, Fredholm S, Blümel E, Nastasi C, Gluud M, Hu T, Lindahl LM, Iversen L, Fogh H, Gniadecki R, Litvinov IV, Persson JL, Bonefeld CM, Geisler C, et al. Single-cell heterogeneity in Sézary syndrome. Blood Advances. 2: 2115-2126. PMID 30139925 DOI: 10.1182/Bloodadvances.2018022608  0.357
2018 Maher AM, Ward CE, Glassman S, Litvinov IV. The Importance of Excluding Cutaneous T-Cell Lymphomas in Patients with a Working Diagnosis of Papuloerythroderma of Ofuji: A Case Series. Case Reports in Dermatology. 10: 46-54. PMID 29606946 DOI: 10.1159/000487473  0.341
2018 Huang Y, Su M, Litvinov I, Jiang X, Zhou Y. LB1481 Inducible T cell kinase upregulation drives proliferation and Th2 immune deviation in cutaneous T cell lymphoma cells Journal of Investigative Dermatology. 138: B3. DOI: 10.1016/J.Jid.2018.06.010  0.309
2018 Lefrançois P, Xie P, Wang L, Tetzlaff M, Ni X, Sasseville D, Wheeler D, Duvic M, Litvinov I. 170 Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients Journal of Investigative Dermatology. 138. DOI: 10.1016/J.Jid.2018.03.175  0.305
2018 Tsang M, Gantchev J, Sasseville D, Litvinov I. 167 Ectopic expression of meiosis proteins and the LINE-1 retrotransposon is associated with genomic instability in cutaneous T-Cell lymphomas Journal of Investigative Dermatology. 138: S28. DOI: 10.1016/J.Jid.2018.03.172  0.304
2018 Ghazawi F, Netchiporouk E, Rahme E, Moreau L, Glassman S, Gilbert M, Sara-Elizabeth J, Pehr K, Sasseville D, Litvinov I. Epidemiology and distribution of cutaneous T-cell lymphoma (CTCL) cases in Canada from 1992 to 2010: Implications of cluster proximity of patients to industrial centers and seaports Journal of the American Academy of Dermatology. 79. DOI: 10.1016/J.Jaad.2018.05.542  0.307
2017 Ghazawi FM, Netchiporouk E, Rahme E, Tsang M, Moreau L, Glassman S, Provost N, Gilbert M, Jean SE, Roshdy O, Pehr K, Sasseville D, Litvinov IV. Distribution and Clustering of Cutaneous T-Cell Lymphoma (CTCL) Cases in Canada During 1992 to 2010. Journal of Cutaneous Medicine and Surgery. 1203475417745825. PMID 29241349 DOI: 10.1177/1203475417745825  0.325
2017 Netchiporouk E, Gantchev J, Tsang M, Thibault P, Watters AK, Hughes JM, Ghazawi FM, Woetmann A, Ødum N, Sasseville D, Litvinov IV. Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome vs. HTLV-1+ leukemic cell lines. Oncotarget. 8: 95981-95998. PMID 29221181 DOI: 10.18632/Oncotarget.21619  0.349
2017 Litvinov IV, Tetzlaff MT, Thibault P, Gangar P, Moreau L, Watters AK, Netchiporouk E, Pehr K, Prieto VG, Rahme E, Provost N, Gilbert M, Sasseville D, Duvic M. Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators. Oncoimmunology. 6: e1306618. PMID 28638728 DOI: 10.1080/2162402X.2017.1306618  0.367
2017 Ghazawi FM, Netchiporouk E, Rahme E, Tsang M, Moreau L, Glassman S, Provost N, Gilbert M, Jean SE, Pehr K, Sasseville D, Litvinov IV. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy. Cancer. PMID 28493286 DOI: 10.1002/Cncr.30758  0.341
2017 Tsang M, Gantchev J, Litvinov I. 100 Does ectopic expression of germ cell proteins contribute to genomic instability in cutaneous T-cell lymphomas? Journal of Investigative Dermatology. 137: S17. DOI: 10.1016/J.Jid.2017.02.114  0.325
2016 Krejsgaard T, Lindahl LM, Mongan NP, Wasik MA, Litvinov IV, Iversen L, Langhoff E, Woetmann A, Odum N. Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover. Seminars in Immunopathology. PMID 27717961 DOI: 10.1007/S00281-016-0594-9  0.346
2016 Litvinov IV, Shtreis A, Kobayashi K, Glassman S, Tsang M, Woetmann A, Sasseville D, Ødum N, Duvic M. Investigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancy. Oncoimmunology. 5: e1175799. PMID 27622024 DOI: 10.1080/2162402X.2016.1175799  0.376
2016 Willerslev-Olsen A, Krejsgaard T, Lindahl LM, Litvinov IV, Fredholm S, Petersen DL, Nastasi C, Gniadecki R, Mongan NP, Sasseville D, Wasik MA, Bonefeld CM, Geisler C, Woetmann A, Iversen L, et al. Staphylococcus aureus enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma. Blood. PMID 26738536 DOI: 10.1182/Blood-2015-08-662353  0.349
2015 Litvinov IV, Tetzlaff MT, Rahme E, Jennings MA, Risser DR, Gangar P, Netchiporouk E, Moreau L, Prieto VG, Sasseville D, Duvic M. Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries. Cancer Medicine. 4: 1440-7. PMID 26136403 DOI: 10.1002/Cam4.472  0.345
2015 Bagdonaite I, Wandall HH, Litvinov IV, Nastasi C, Becker JC, Dabelsteen S, Geisler C, Bonefeld CM, Zhang Q, Wasik MA, Zhou Y, Sasseville D, Ødum N, Woetmann A. Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients. Oncotarget. 6: 14374-84. PMID 25957418 DOI: 10.18632/Oncotarget.3720  0.311
2015 Litvinov IV, Netchiporouk E, Cordeiro B, Doré MA, Moreau L, Pehr K, Gilbert M, Zhou Y, Sasseville D, Kupper TS. The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2820-9. PMID 25779945 DOI: 10.1158/1078-0432.Ccr-14-3322  0.337
2015 Litvinov IV, Tetzlaff MT, Rahme E, Habel Y, Risser DR, Gangar P, Jennings MA, Pehr K, Prieto VG, Sasseville D, Duvic M. Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registries. Cancer. 121: 1993-2003. PMID 25728286 DOI: 10.1002/Cncr.29301  0.356
2014 Litvinov IV, Netchiporouk E, Cordeiro B, Zargham H, Pehr K, Gilbert M, Zhou Y, Moreau L, Woetmann A, Ødum N, Kupper TS, Sasseville D. Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphoma. Oncoimmunology. 3: e970025. PMID 25941598 DOI: 10.4161/21624011.2014.970025  0.346
2014 Litvinov IV, Cordeiro B, Fredholm S, Ødum N, Zargham H, Huang Y, Zhou Y, Pehr K, Kupper TS, Woetmann A, Sasseville D. Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines. Cell Cycle (Georgetown, Tex.). 13: 2975-82. PMID 25486484 DOI: 10.4161/15384101.2014.947759  0.348
2014 Netchiporouk E, Litvinov IV, Moreau L, Gilbert M, Sasseville D, Duvic M. Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression. Cell Cycle (Georgetown, Tex.). 13: 3331-5. PMID 25485578 DOI: 10.4161/15384101.2014.965061  0.304
2014 Vander Griend DJ, Litvinov IV, Isaacs JT. Conversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c-Myc regulation. International Journal of Biological Sciences. 10: 627-42. PMID 24948876 DOI: 10.7150/Ijbs.8756  0.555
2014 Huang Y, Litvinov IV, Wang Y, Su MW, Tu P, Jiang X, Kupper TS, Dutz JP, Sasseville D, Zhou Y. Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis. Oncotarget. 5: 4418-25. PMID 24947046 DOI: 10.18632/Oncotarget.2031  0.325
2014 Litvinov IV, Cordeiro B, Huang Y, Zargham H, Pehr K, Doré MA, Gilbert M, Zhou Y, Kupper TS, Sasseville D. Ectopic expression of cancer-testis antigens in cutaneous T-cell lymphoma patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3799-808. PMID 24850846 DOI: 10.1158/1078-0432.Ccr-14-0307  0.357
2013 Litvinov IV, Pehr K, Sasseville D. Connecting the dots in cutaneous T cell lymphoma (CTCL): STAT5 regulates malignant T cell proliferation via miR-155. Cell Cycle (Georgetown, Tex.). 12: 2172-3. PMID 23803726 DOI: 10.4161/Cc.25550  0.337
2012 Litvinov IV, Kupper TS, Sasseville D. The role of AHI1 and CDKN1C in cutaneous T-cell lymphoma progression. Experimental Dermatology. 21: 964-6. PMID 23171462 DOI: 10.1111/Exd.12039  0.364
2011 Williams SA, Jelinek CA, Litvinov I, Cotter RJ, Isaacs JT, Denmeade SR. Enzymatically active prostate-specific antigen promotes growth of human prostate cancers. The Prostate. 71: 1595-607. PMID 21394741 DOI: 10.1002/Pros.21375  0.531
2010 Litvinov IV, Jones DA, Sasseville D, Kupper TS. Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 2106-14. PMID 20233883 DOI: 10.1158/1078-0432.Ccr-09-2879  0.326
2007 Vander Griend DJ, Litvinov IV, Isaacs JT. Stabilizing androgen receptor in mitosis inhibits prostate cancer proliferation. Cell Cycle (Georgetown, Tex.). 6: 647-51. PMID 17387277 DOI: 10.4161/Cc.6.6.4028  0.562
2006 Litvinov IV, Vander Griend DJ, Antony L, Dalrymple S, De Marzo AM, Drake CG, Isaacs JT. Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 103: 15085-90. PMID 17015840 DOI: 10.1073/Pnas.0603057103  0.56
2006 Singh P, Uzgare A, Litvinov I, Denmeade SR, Isaacs JT. Combinatorial androgen receptor targeted therapy for prostate cancer. Endocrine-Related Cancer. 13: 653-66. PMID 16954423 DOI: 10.1677/Erc.1.00797  0.687
2006 Litvinov IV, Vander Griend DJ, Xu Y, Antony L, Dalrymple SL, Isaacs JT. Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells. Cancer Research. 66: 8598-607. PMID 16951173 DOI: 10.1158/0008-5472.Can-06-1228  0.54
2006 Litvinov IV, Antony L, Dalrymple SL, Becker R, Cheng L, Isaacs JT. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor. The Prostate. 66: 1329-38. PMID 16835890 DOI: 10.1002/Pros.20483  0.563
2004 Litvinov IV, Antony L, Isaacs JT. Molecular characterization of an improved vector for evaluation of the tumor suppressor versus oncogene abilities of the androgen receptor. The Prostate. 61: 299-304. PMID 15499637 DOI: 10.1002/Pros.20187  0.547
2004 Litvinov IV, Chang C, Isaacs JT. Molecular characterization of the commonly used human androgen receptor expression vector, pSG5-AR. The Prostate. 58: 319-24. PMID 14968432 DOI: 10.1002/Pros.20027  0.498
2003 Litvinov IV, De Marzo AM, Isaacs JT. Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling? The Journal of Clinical Endocrinology and Metabolism. 88: 2972-82. PMID 12843129 DOI: 10.1210/Jc.2002-022038  0.566
2003 Denmeade SR, Litvinov I, Sokoll LJ, Lilja H, Isaacs JT. Prostate-specific antigen (PSA) protein does not affect growth of prostate cancer cells in vitro or prostate cancer xenografts in vivo. The Prostate. 56: 45-53. PMID 12746846 DOI: 10.1002/Pros.10213  0.548
Show low-probability matches.